Literature DB >> 7731969

In vivo estimates of division and death rates of human T lymphocytes.

A R Mclean1, C A Michie.   

Abstract

We present data on the decay, after radiotherapy, of naive and memory human T lymphocytes with stable chromosome damage. These data are analyzed in conjunction with existing data on the decay of naive and memory T lymphocytes with unstable chromosome damage and older data on unsorted lymphocytes. The analyses yield in vivo estimates for some life-history parameters of human T lymphocytes. Best estimates of proliferation rates have naive lymphocytes dividing once every 3.5 years and memory lymphocytes dividing once every 22 weeks. It appears that memory lymphocytes can revert to the naive phenotype, but only, on average, after 3.5 years in the memory class. The lymphocytes with stable chromosome damage decay very slowly, yielding surprisingly low estimates of their death rate. The estimated parameters are used in a simple mathematical model of the population dynamics of undamaged naive and memory lymphocytes. We use this model to illustrate that it is possible for the unprimed subset of a constantly stimulated clone to stay small, even when there is a large population of specific primed cells reverting to the unprimed state.

Entities:  

Mesh:

Year:  1995        PMID: 7731969      PMCID: PMC42030          DOI: 10.1073/pnas.92.9.3707

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  TIME CULTURE. AN IMPORTANT VARIABLE IN STUDYING IN VIVO RADIATION-INDUCED CHROMOSOME DAMAGE IN MAN.

Authors:  K E BUCKTON; M C PIKE
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1964

2.  Cytotoxic T-cell memory without antigen.

Authors:  L L Lau; B D Jamieson; T Somasundaram; R Ahmed
Journal:  Nature       Date:  1994-06-23       Impact factor: 49.962

Review 3.  Is T-cell memory maintained by crossreactive stimulation?

Authors:  P C Beverley
Journal:  Immunol Today       Date:  1990-06

Review 4.  Immune network theory.

Authors:  A S Perelson
Journal:  Immunol Rev       Date:  1989-08       Impact factor: 12.988

5.  Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.

Authors:  A N Akbar; L Terry; A Timms; P C Beverley; G Janossy
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

6.  Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: implications for differential CD45 expression in T cell memory formation.

Authors:  M Merkenschlager; L Terry; R Edwards; P C Beverley
Journal:  Eur J Immunol       Date:  1988-11       Impact factor: 5.532

Review 7.  The balance of power between HIV and the immune system.

Authors:  A R McLean
Journal:  Trends Microbiol       Date:  1993-04       Impact factor: 17.079

Review 8.  Lymphocyte life-span and memory.

Authors:  J Sprent; D F Tough
Journal:  Science       Date:  1994-09-02       Impact factor: 47.728

9.  Lymphocyte survival in men treated with x-rays for ankylosing spondylitis.

Authors:  K E Buckton; W M Brown; P G Smith
Journal:  Nature       Date:  1967-04-29       Impact factor: 49.962

10.  Naive and memory T cells show distinct pathways of lymphocyte recirculation.

Authors:  C R Mackay; W L Marston; L Dudler
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

View more
  64 in total

1.  Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: correlation with disease progression.

Authors:  G S Ogg; S Kostense; M R Klein; S Jurriaans; D Hamann; A J McMichael; F Miedema
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.

Authors:  D Persaud; T Pierson; C Ruff; D Finzi; K R Chadwick; J B Margolick; A Ruff; N Hutton; S Ray; R F Siliciano
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 3.  Differences in the regulation of CD4 and CD8 T-cell clones during immune responses.

Authors:  P C Beverley; M K Maini
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

4.  Reservoirs for HIV-1.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

5.  Production of resistant HIV mutants during antiretroviral therapy.

Authors:  R M Ribeiro; S Bonhoeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

6.  Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy.

Authors:  H Mohri; A S Perelson; K Tung; R M Ribeiro; B Ramratnam; M Markowitz; R Kost; A Hurley; L Weinberger; D Cesar; M K Hellerstein; D D Ho
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

7.  Influence of follicular dendritic cells on decay of HIV during antiretroviral therapy.

Authors:  W S Hlavacek; N I Stilianakis; D W Notermans; S A Danner; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

8.  Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence.

Authors:  M C Strain; H F Günthard; D V Havlir; C C Ignacio; D M Smith; A J Leigh-Brown; T R Macaranas; R Y Lam; O A Daly; M Fischer; M Opravil; H Levine; L Bacheler; C A Spina; D D Richman; J K Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-08       Impact factor: 11.205

9.  Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.

Authors:  T Pierson; T L Hoffman; J Blankson; D Finzi; K Chadwick; J B Margolick; C Buck; J D Siliciano; R W Doms; R F Siliciano
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 10.  Latency in human immunodeficiency virus type 1 infection: no easy answers.

Authors:  Deborah Persaud; Yan Zhou; Janet M Siliciano; Robert F Siliciano
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.